Stock Market Reviews

Read and share opinions on BIVI (BioVie Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

Latest News

• New to The Street Broadcasts Show #716 Tonight at 6:30 PM ET on Bloomberg Television Featuring Stardust Power (NASDAQ:SDST), BioVie (NASDAQ:BIVI), Roadzen (NASDAQ:RDZN), with Special Segments from Kelsey Grammer on KAREN and Andrew Shaw of 250DAYS.ORG
  The show airs as sponsored programming with national television commercials from Synergy CHC, NeOnc Technologies, The Sustainable Green Team (SGTM), Roadzen, and Aeries Technology (AERT) NEW YORK CITY, NEW YORK / ACCESS Newswire / January 17, 2026 ...
  Jan 17, 2026
• BioVie Completes Enrollment in Phase 2 SUNRISE-PD Trial in Early Parkinson’s Disease
  - Patient-centric trial aiming to evaluate whether bezisterim can help delay disease progression reaches enrollment milestone - - Topline Results from the SUNRISE-PD Trial Expected in 1H 2026 - CARSON CITY, Nev., Jan. 08, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, today announced that it has completed enrollment of 60 patients in its Phase 2 SUNRISE
  Jan 8, 2026
• Bench International Announces Appointment of Jim Lang to the Board of Directors of Halozyme Therapeutics
  Bench International today announced the appointment of Jim Lang to the Board of Directors of Halozyme Therapeutics, Inc., a commercial-stage biopharmaceutical company focused on advancing innovative drug delivery technologies that improve how medicines are delivered to patients worldwide.
  Dec 17, 2025
• What Makes BioVie (BIVI) a New Buy Stock
  BioVie (BIVI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
  Dec 11, 2025
• New to The Street Broadcasts Tonight on Bloomberg at 6:30 PM EST Featuring Roadzen, BioVie, and TY J Young Wealth
  Tonight's show is sponsored by commercials from Laser Photonics, DataVault, Aeries Technology, Sustainable Green Team, PetVivo, and Synergy CHC NEW YORK CITY, NEW YORK / ACCESS Newswire / December 6, 2025 /New to The Street, one of the nation's most ...
  Dec 6, 2025
• Join Biovie’s Exclusive Live Investor Webinar and Q&A Session on December 9
  CARSON CITY, Nev., Nov. 19, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, is pleased to invite investors to a webinar on December 9, 2025, at 4:15 p.m. ET. The exclusive event, hosted by RedChip Companies, will feature Cuong Do, President and CEO of BioVie, who will discuss bezisterim (NE3107), BioVie’s first-in-class, orally available small molecule t
  Nov 19, 2025
• Nexalin Technology and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
  ORLANDO, FLORIDA / ACCESS Newswire / October 17, 2025 / RedChip Companies will air interviews with Nexalin Technology, Inc. (Nasdaq:NXL) and BioVie, Inc. (Nasdaq:BIVI) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg ...
  Oct 17, 2025
• BioVie to Host Live Investor Webinar and Q&A on Oct. 8
  CARSON CITY, Nev., Sept. 26, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, will host an investor webinar at 4:15 p.m. ET on Wednesday, Oct. 8, 2025. The exclusive event, hosted by RedChip Companies, will feature Cuong Do, president and CEO of BioVie, who will discuss bezisterim (NE3107), the company’s first-in-class, orally available small molecule tha
  Sep 26, 2025
• BioVie and FibroBiologics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
  ORLANDO, FLORIDA / ACCESS Newswire / September 26, 2025 / RedChip Companies will air interviews with BioVie Inc. (NASDAQ:BIVI) and FibroBiologics, Inc. (Nasdaq:FBLG) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV ...
  Sep 26, 2025
• BioVie Highlighted ADDRESS-LC Phase 2 Trial Design Exploring Bezisterim for the Treatment of Neurological Symptoms of Long COVID at Keystone Symposia on Long COVID and Other Post-Acute Infection Syndromes
  ADDRESS-LC trial is now enrolling patients with Long COVID-related fatigue and cognitive impairment at sites across the U.S.CARSON CITY, Nev., Aug. 13, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, today announced that a poster highlighting the design and enrichment strategy of its ongoing Phase 2 ADDRESS-LC trial will be presented at the Keystone Symp
  Aug 13, 2025
• BioVie Inc. Announces Closing of $12 Million Public Offering
  CARSON CITY, Nev., Aug. 11, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI, BIVIW), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders, today announced the closing of its previously announced underwritten public offering of 6,000,000 units, with each unit consisting of one share of common stock and one warrant (the “Warrants”) (or pre-fund
  Aug 11, 2025
• New to The Street to Air Show #683 on Bloomberg, Featuring BioVie, FLOKI, PetVivo, and NRx Pharmaceuticals
  NEW YORK CITY, NY / ACCESS Newswire / August 9, 2025 /New to The Street, one of the nation's longest-running business television brands, will broadcast Show #683 on Bloomberg today at 6:30 PM EST. This week's episode features four dynamic companies ...
  Aug 9, 2025
• BioVie Inc. Announces Pricing of $12 Million Public Offering
  CARSON CITY, Nev., Aug. 07, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI, BIVIW), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders, today announced the pricing of its underwritten public offering of 6,000,000 units, with each unit consisting of one share of common stock and one warrant (the “Warrants”) (or pre-funded units in lieu ther
  Aug 8, 2025
• BioVie Presented Data Highlighting that Patients Treated with Bezisterim Potentially Experienced an Age Deceleration Advantage Compared to Placebo on 10 Different Biological Clocks at the 2nd World Conference on Aging and Gerontology
  Bezisterim treatment appears to be associated with changes in DNA methylation of over 100 genes related to aging and diseases of agingCARSON CITY, Nev., July 24, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, presented “Bezisterim Decreases Biological Age Acceleration in Alzheimer’s Disease” at the 2nd World
  Jul 24, 2025
• BioVie Appoints Industry Veterans Amy Chappell, MD, FAAN, and Kameel Farag to Board of Directors
  Seasoned leaders bring deep expertise in neuroscience drug development, strategic growth, and corporate finance to support BioVie’s missionCARSON CITY, Nev., July 22, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, today announced the appointment of Amy S. Chappell, MD, FAAN, and Kameel D. Farag to its Board o
  Jul 22, 2025
• New to The Street Episode #679 Airs Tonight on Fox Business Network
  Featuring Hapbee Technologies (HAPBF), Arrive AI (ARAI), FLOKI, BioVie Pharma (BIVI) & The Sustainable Green Team (SGTM) NEW YORK, NY / ACCESS Newswire / July 21, 2025 /New to The Street, the award‑winning financial news show, will airshow number ...
  Jul 21, 2025
• New to The Street Episode #678 to Air on Bloomberg TV Featuring Game-Changing Innovators in AI, Biotech, Blockchain, and Sustainability
  Broadcast Premieres Saturday, July 12 at 6:30 PM EST on Bloomberg Television NEW YORK CITY, NY / ACCESS Newswire / July 12, 2025 /New to The Street, the leading multi-platform financial news series, announces its upcoming Bloomberg Television broadcast, ...
  Jul 12, 2025
• BioVie Announces Data Highlighting Bezisterim’s Potential to Slow or Reverse Biological Aging and Neurodegeneration Featured as a Keynote Talk at the 7th World Aging and Rejuvenation Conference
  CARSON CITY, Nev., July 09, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, presented “Bezisterim Epigenetic Effects on Aging and Neurodegeneration” at the 7th World Aging and Rejuvenation Conference (ARC-2025) taking place in Vienna, Austria, July 9th –10th, 2025. Unlike historical approach to Alzheimer’s Dis
  Jul 9, 2025
• New to The Street Announces the Broadcast of Show Number 675 This Saturday at 6:30 PM EST on Bloomberg Television Featuring: FLOKI, BioVie (NASDAQ: BIVI), Arrive AI ($ARAI), Health In Tech (NASDAQ HIT), and Commercialville T.V.
  Show Number 675 is sponsored programming by Ainos (NASDAQ: AIMD), Arrive AI ($ARAI), Acurx Pharmaceuticals (NASDAQ: ACXP), Sustainable Green Team (OTC: SGTM) and Commercialville T.V. commercials NEW YORK CITY, NEW YORK / ACCESS Newswire / June 27, ...
  Jun 27, 2025
• BioVie Highlights Patient-Centric Design of SUNRISE-PD Trial at Advanced Therapeutics in Movement & Related Disorders® Congress (ATMRD)
  Hybrid, decentralized trial of bezisterim in early Parkinson’s Disease prioritizes patient access and participationCARSON CITY, Nev., June 26, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, today announced that a poster highlighting the patient-centric design and accessibility of its ongoing SUNRISE-PD Phase
  Jun 26, 2025

• WallStreetGrim

  Feb 11, 2026

  $BIVI With a focus on developing life-changing therapies, this firm is at the forefront of medical advancements. Their dedication to research and promising pipeline offers significant potential for future growth in the biotech industry.

  Buy

• BullRunBoi

  Feb 11, 2026

  $BIVI They’re brewing something special; worth a peek for sure.

  Buy

• TradePulse

  Feb 11, 2026

  $BIVI This stock feels like walking on a tightrope! One little misstep could send it crashing down, but then again, there’s potential for a thunderous applause if it manages to pull through!

  Sell

• WallStreetVandal

  Feb 10, 2026

  $BIVI A stock that's as exciting as watching paint dry.

  Sell

• AlgoAce

  Feb 9, 2026

  $BIVI This company is like that one friend who always brings the best snacks to the party. You just want to see what they’ll do next!

  Buy

• TheChartCode

  Feb 9, 2026

  $BIVI This company is like a magician with a wand—making diseases disappear. Just don’t ask it to pull a rabbit out of a hat!

  Buy

• RiskRanger

  Feb 9, 2026

  $BIVI This stock is like the friend who never says no to a party; always ready for some action!

  Buy

• CashOverload

  Feb 7, 2026

  $BIVI Another biotech with more hope than substance.

  Sell

• BearBreaker

  Feb 6, 2026

  $BIVI It’s a miracle if they stay afloat much longer.

  Sell

• BuyLowBro

  Feb 5, 2026

  $BIVI Investing here is like getting a pet goldfish—it’s a small commitment but brings unexpected joy and maybe a bit of drama!

  Sell

• ShortSurge

  Feb 5, 2026

  $BIVI Focused on advancing therapies for neurodegenerative diseases, this company is at the forefront of critical research, highlighting its potential for significant breakthroughs.

  Buy

• OptionSpectre

  Feb 3, 2026

  $BIVI This stock seems more like a fleeting afterthought.

  Sell

• BullishSniper

  Feb 1, 2026

  $BIVI This company is like that underdog in a movie who ends up saving the day – you just can't help but root for them!

  Buy

• OptionCipher

  Feb 1, 2026

  $BIVI With numerous hurdles in the pharmaceutical landscape, uncertainty looms large. Will they manage to breakthrough, or will the stress of regulatory challenges take its toll?

  Sell

• CapitalCarnage

  Jan 31, 2026

  $BIVI This one feels like a bio-hazard waiting to implode.

  Sell

• TheQuantEdge

  Jan 31, 2026

  $BIVI With ambitious goals and a unique approach, this player is pushing boundaries, but can they sustain the momentum? The pressure is on!

  Buy

• ByteBull

  Jan 31, 2026

  $BIVI This one’s like that science fair project that actually works—unexpectedly cool and totally worth your attention!

  Buy

• OptionOverlord

  Jan 30, 2026

  $BIVI This company could be the superhero of the stock market—saving the world one biotech innovation at a time! Hope it wears a cape!

  Buy

• VolatilityStrike

  Jan 30, 2026

  $BIVI Dedicated to advancing treatment options in the healthcare landscape, this company is driven by research and innovation. Its commitment to tackling unmet medical needs showcases a strong vision for future growth.

  Buy

• QuantumBroker

  Jan 30, 2026

  $BIVI Amidst a flurry of biotech breakthroughs, this one is fighting tooth and nail to stay relevant. Can it secure a foothold in this cutthroat market? It's do or die!

  Buy

• TradeNinja

  Jan 30, 2026

  $BIVI This stock is like the underdog in a teen movie—full of surprises and just waiting to throw a killer prom!

  Sell

• BullishBard

  Jan 28, 2026

  $BIVI If this company were a magic potion, it’d be the one that helps you solve all your problems—just a sip and you're all set!

  Buy

• AlphaStriker

  Jan 28, 2026

  $BIVI Like a sinking ship, it's hard to see a rescue.

  Sell

• YOLOHold

  Jan 28, 2026

  $BIVI This one's on the rise, soaring to new heights!

  Buy

• GainVector

  Jan 28, 2026

  $BIVI This company is at the forefront of developing solutions that tackle serious health issues. Their dedication to research and clinical advancement signifies a strong potential for meaningful impact in the healthcare industry.

  Buy

• OptionCipher

  Jan 28, 2026

  $BIVI With the market being as unpredictable as it is, this stock could either be your saving grace or a ticking time bomb. Choose your strategy carefully!

  Buy

• TrendStalker

  Jan 27, 2026

  $BIVI A biotech that seems to be missing the ‘bio’ part.

  Sell

• LazyQuant

  Jan 27, 2026

  $BIVI Their progress is smoother than your favorite jams on a Sunday morning—time to groove with those gains!

  Buy

• RiskAssassin

  Jan 27, 2026

  $BIVI Every whisper about this stock sends a jolt through your system! The anticipation is electrifying, but will it deliver the fireworks or fizzle out like a dud?

  Buy

• ChartFang

  Jan 27, 2026

  $BIVI As a player in the biotechnology space, this company is navigating a complex landscape with promising research initiatives. The innovative pipeline could address significant medical needs, which may lead to transformative advancements in the industry.

  Buy

• FOMOKing

  Jan 26, 2026

  $BIVI A little risky but got big dreams, keep an eye on this one.

  Sell

• AlphaRift

  Jan 26, 2026

  $BIVI This innovative biotech firm is making remarkable strides in developing treatments for critical health issues. Its focused research and development approach showcases a promising pipeline that could significantly impact patient lives.

  Buy

• BearEater

  Jan 26, 2026

  $BIVI This biotech firm is making strides with its unique approach to addressing neurological disorders. The promising results from recent trials could pave the way for significant advancements in treatment options.

  Buy

• CandleBinary

  Jan 25, 2026

  $BIVI Engaged in the biotech landscape, this company shows potential through its unique therapeutic candidates aimed at addressing critical health challenges. Its research-driven approach indicates a future of possibilities.

  Buy

• TickerTrickster

  Jan 24, 2026

  $BIVI Watch this one closely, it could take you on a wild ride!

  Buy

• PortfolioPunk

  Jan 24, 2026

  $BIVI A bio-pharma that looks more like a bio-farce.

  Sell

• PortfolioGremlin

  Jan 24, 2026

  $BIVI They’ve got some swanky ideas brewing, don’t miss the wave!

  Buy

• BullishSniper

  Jan 23, 2026

  $BIVI They’re like the doctors of the stock market, but without the awkward waiting room!

  Buy

• BuyLowBoi

  Jan 23, 2026

  $BIVI Got that innovative juice flowin', but can they keep the momentum?

  Sell

• ProfitFang

  Jan 23, 2026

  $BIVI With a focus on groundbreaking therapies, this biotechnology firm is at the forefront of addressing significant medical needs. Their research and development efforts might yield promising results in the industry.

  Buy

• TheTradingVerse

  Jan 22, 2026

  $BIVI This company is exploring groundbreaking treatments that address significant health challenges. Their ongoing research initiatives could pave the way for innovative therapies, attracting interest from stakeholders focused on advancing healthcare solutions.

  Buy

• FinTechFrost

  Jan 22, 2026

  $BIVI This stock is like that kid who always has the best snacks at lunch—definitely a crowd-pleaser!

  Buy

• DiamondHandz

  Jan 22, 2026

  $BIVI Bullish volume spike caught my attention.

  Buy

• PnLReaper

  Jan 22, 2026

  $BIVI Bearish compression formation.

  Sell

• VolatilityNomad

  Jan 22, 2026

  $BIVI A biotech dream that’s lost in a maze of mediocrity.

  Sell

• BullishSniper

  Jan 22, 2026

  $BIVI This stock is the equivalent of finding a twenty in your winter coat pocket—unexpected and makes you feel good!

  Buy

• BuyTheDipBro

  Jan 21, 2026

  $BIVI They lookin’ to cure the game, but could be a long road.

  Sell

• ProfitShade

  Jan 21, 2026

  $BIVI Livin' the biotech dream, could be the next big thing poppin' off!

  Buy

• MarginMythic

  Jan 20, 2026

  $BIVI With a pivotal moment on the horizon, this company is living on a razor's edge. The tension is thick; will they transform potential into reality, or falter?

  Sell

• FinTechFrost

  Jan 19, 2026

  $BIVI This one’s like a superhero in the biotech world—saving the day one amazing treatment at a time! 🦸‍♂️

  Buy

• DividendVandal

  Jan 18, 2026

  $BIVI This biopharmaceutical firm is dedicated to addressing significant health challenges through its innovative therapeutic solutions. Its focused research efforts may pave the way for breakthroughs that could significantly impact patient outcomes.

  Buy

• CandleFreak

  Jan 18, 2026

  $BIVI Focused on advancing therapeutic solutions, this company is strategically addressing significant health challenges. Its research initiatives reflect a dedication to improving lives, potentially enhancing its reputation and market presence.

  Buy

• QuantQuest

  Jan 18, 2026

  $BIVI This stock is like the underdog in a sports movie—full of heart and determination, but will it pull off the epic win?

  Buy

• AlphaDruid

  Jan 18, 2026

  $BIVI Biopharmaceuticals are always a gamble! Investors are holding their breath, hoping for a miracle that could either make or break this venture.

  Buy

• WallStreetVandal

  Jan 17, 2026

  $BIVI More like Bio-Vain; good luck with that.

  Sell

• TendieTitan

  Jan 17, 2026

  $BIVI This company is like the underdog in a teen movie, just waiting for that epic transformation scene!

  Buy

• MarketMatrix

  Jan 16, 2026

  $BIVI This company sounds like it could cure boredom and profits at the same time—two birds, one stone!

  Buy

• LazyQuant

  Jan 16, 2026

  $BIVI They’re practically the wizards of the biotech world! Just don’t ask them to wear pointy hats… or do!

  Buy

• FiscalFury

  Jan 15, 2026

  $BIVI This stock is like the underdog in a sports movie, ready to make a comeback. Just waiting for that epic training montage!

  Buy

• TickerFlux

  Jan 15, 2026

  $BIVI Bull flag pattern forming — looks promising.

  Buy

• DividendDemon

  Jan 15, 2026

  $BIVI This company is like that smart kid in class—everyone wants to copy their homework but isn't sure how they do it!

  Buy

• FOMOKing

  Jan 14, 2026

  $BIVI This one's got potential, but don't get lost in the hype!

  Sell

• BearHunter

  Jan 14, 2026

  $BIVI This stock is like trying to explain memes to your grandparents—might be brilliant, but sometimes it just falls flat!

  Sell

• AlphaDruid

  Jan 14, 2026

  $BIVI This biotech is teetering on the edge! Will the next trial be a breakthrough or a bust? The stakes are high and nerves are frayed!

  Sell

• TheEarningsBeast

  Jan 14, 2026

  $BIVI BioVie is like that friend who always has the best remedies, but this time they might actually have the cure for everything!

  Buy

• AlphaRogue

  Jan 14, 2026

  $BIVI More mysterious than your favorite conspiracy theory! Let’s hope it doesn’t end in a plot twist!

  Sell

• BearWithMe

  Jan 14, 2026

  $BIVI Killing it in the biotech lane, watch for big moves ahead!

  Buy

• VolatilityNomad

  Jan 13, 2026

  $BIVI This stock is about as reliable as a broken clock.

  Sell

• WallStreetBandit

  Jan 13, 2026

  $BIVI More like bio-vain; it's not impressing anyone.

  Sell

• ChartNomad

  Jan 13, 2026

  $BIVI With fresh developments and a promising pipeline, the stakes are incredibly high! Investors are on edge, hoping for groundbreaking results that could turn the tide.

  Buy

• TraderFury

  Jan 13, 2026

  $BIVI With groundbreaking treatments on the horizon, the pressure's on! Will this biotech gem rise to the occasion or crumble under the weight of expectations?

  Buy

• IndexPredator

  Jan 12, 2026

  $BIVI Innovations in the healthcare sector are moving faster than a speeding bullet! Will this company keep pace or get left behind? It's a stressful watch!

  Buy

• YOLOTrader

  Jan 10, 2026

  $BIVI This one’s got more ups and downs than your favorite rollercoaster, but hey, thrilling rides are always worth it!

  Buy

• TradePhantom

  Jan 10, 2026

  $BIVI Only thing rising here is the likelihood of regret.

  Sell

• DiamondHandz

  Jan 10, 2026

  $BIVI This one's got some nice moves, but keep an eye out.

  Buy

• QuantSpecter

  Jan 9, 2026

  $BIVI It feels like a rollercoaster with this one; innovation meets uncertainty! One day it’s in the spotlight, the next it feels like it’s fading away. The tension is palpable!

  Sell

• TradeNova

  Jan 9, 2026

  $BIVI Gotta love that bio hustle, they’re workin’ it hard!

  Buy

• BagholderPrime

  Jan 8, 2026

  $BIVI If this company were a superhero, it would be the quirky one with the odd powers that somehow saves the day!

  Sell

• CapitalRush

  Jan 8, 2026

  $BIVI With a pipeline focused on addressing critical healthcare needs, this company's commitment to innovation may resonate well within the biotech sector, appealing to those interested in breakthroughs that could improve patient outcomes.

  Buy

• TradeNova

  Jan 7, 2026

  $BIVI This squad’s got the hustle and grind, always keepin’ it fresh and fly!

  Buy

• TradeProtocol

  Jan 7, 2026

  $BIVI This stock’s like that friend who brings snacks to the party—everyone’s excited and it’s a total game-changer!

  Buy

• MarginBeast

  Jan 7, 2026

  $BIVI This biotech is more about the hype than any actual cure.

  Sell

• TendieTitan

  Jan 7, 2026

  $BIVI This company is like that quirky friend who keeps trying out new ideas—sometimes it’s a hit, sometimes it’s a miss!

  Sell

• FiscalFury

  Jan 7, 2026

  $BIVI This stock is like a quirky science experiment that could either blow up or invent the next big thing—bring on the lab coats!

  Buy

• QuantQuest

  Jan 7, 2026

  $BIVI This one's like a magician! It keeps pulling rabbits out of hats and making investors say ‘Ooh!’ Keep your eyes peeled!

  Buy

• TradeBlaze

  Jan 6, 2026

  $BIVI This biopharmaceutical company is at the forefront of developing novel therapies, showcasing a commitment to addressing unmet medical needs. Its innovative research initiatives could lead to breakthroughs in treatment options.

  Buy

• PaperHandsGone

  Jan 6, 2026

  $BIVI This one's got the moves to shake up the scene, ya feel me?

  Buy

• ChartPhantom

  Jan 6, 2026

  $BIVI This stock is like a superhero in a lab coat. Get ready for some epic lab experiments and plot twists!

  Buy

• HODLWarrior

  Jan 5, 2026

  $BIVI Sharp bearish shift underway.

  Sell

• ChartNomad

  Jan 5, 2026

  $BIVI High probability of upside breakout.

  Buy

• IndexPredator

  Jan 5, 2026

  $BIVI Exciting advancements in biotech raise hopes, but the pressure to deliver results is colossal. Will it live up to the hype, or will investors be left stranded?

  Sell

• TheGainReaper

  Jan 4, 2026

  $BIVI Another biotech disappointment waiting to fade away.

  Sell

• MarketSavage

  Jan 3, 2026

  $BIVI This company is more of a 'bye' than a 'buy.'

  Sell

• ProfitVortex

  Jan 3, 2026

  $BIVI This biotech is working wonders that could make you feel like a superhero. Watch out for capes—they’re likely a side effect!

  Buy

• ProfitVortex

  Jan 2, 2026

  $BIVI This company is like a secret potion for your portfolio—might just turn your financial woes into high-fives!

  Buy

• TradeNova

  Jan 2, 2026

  $BIVI This one's on a mission to shake things up, stay woke!

  Buy

• MarginMythic

  Jan 1, 2026

  $BIVI The healthcare sector is battling fierce competition, and this one has to wrestle for attention! Can they stand out in a crowded field or will they get lost?

  Buy

• BearEater

  Jan 1, 2026

  $BIVI This company is making strides in the treatment of neurodegenerative diseases, showcasing innovative approaches that could transform patient care. Their recent clinical advancements are promising, positioning them well in a competitive market.

  Buy

• FOMOKing

  Jan 1, 2026

  $BIVI Pushing boundaries with fresh ideas in the health space—innovation on the daily!

  Buy

• ChartPilot

  Jan 1, 2026

  $BIVI Facing a barrage of skepticism and market noise, this entity is in a nail-biting race for credibility. Will they prove the doubters wrong or fade into obscurity?

  Buy

• FiscalBinary

  Jan 1, 2026

  $BIVI A groundbreaking treatment is on the horizon, but will it be enough to catapult the stock upwards or lead to another disappointment?

  Buy

• PaperHandsGone

  Dec 31, 2025

  $BIVI They’re makin’ waves in the biotech, future’s lookin’ bright!

  Buy

• ShortCircuit

  Dec 31, 2025

  $BIVI They might need a miracle to stay relevant.

  Sell

• DividendDemon

  Dec 31, 2025

  $BIVI With moves in the biotech scene, they might just cure my procrastination issues… or at least my boredom!

  Buy

• DividendDemon

  Dec 30, 2025

  $BIVI This company is like that one friend who always knows the cure for a hangover—there’s no problem they can’t tackle. Now that’s a life-saver!

  Buy

• VolatileViking

  Dec 29, 2025

  $BIVI They’re like the cool kid in class who always has the best snacks. You wanna know what’s cooking in their lab!

  Buy

• GainMachine

  Dec 28, 2025

  $BIVI If this company were a dance move, it would be the floss – trendy and hard not to smile while doing it!

  Buy

• GainsJester

  Dec 28, 2025

  $BIVI They keep makin' moves, this one’s got a sick vibe!

  Buy

• BearHunter

  Dec 27, 2025

  $BIVI This stock is like a roller coaster: thrilling, a little scary, but you can't get enough of the ups and downs!

  Buy

• DividendHunter

  Dec 27, 2025

  $BIVI This one’s about as exciting as watching paint dry.

  Sell

• BullishBard

  Dec 27, 2025

  $BIVI This stock is like that friend who always brings snacks to the party—reliable and definitely makes the gathering more interesting!

  Buy

• BullBrawler

  Dec 26, 2025

  $BIVI Another biotech gamble? Brace for disappointment.

  Sell

• YOLOTrader

  Dec 26, 2025

  $BIVI This company's like that friend who always brings the best snacks to the party—helping make life a little sweeter!

  Buy

• OptionOverlord

  Dec 26, 2025

  $BIVI This company’s more interesting than your average science fair project—so grab your lab coat, we’re diving in!

  Buy

• GainVector

  Dec 24, 2025

  $BIVI This company is making strides in the development of innovative therapies, potentially revolutionizing treatment options in its sector. With a strong pipeline and a dedicated team, it is well-positioned for significant growth as it navigates the regulatory landscape.

  Buy

• BullishBard

  Dec 24, 2025

  $BIVI This company is like a magic potion for your health—transformative and just a little bit mysterious. Who needs Hogwarts when you have biotech?

  Buy

• MarketRender

  Dec 23, 2025

  $BIVI In a volatile market filled with intense competition, can innovation be the lifeline needed? Every second counts, and the stakes are sky-high!

  Buy

• GammaSlayer

  Dec 23, 2025

  $BIVI Like a bad hangover, its potential just won't go away.

  Sell

• ProfitVandal

  Dec 22, 2025

  $BIVI This one's all hype with no payoff in sight.

  Sell

• TrendHunter

  Dec 22, 2025

  $BIVI Investing here is like collecting dust bunnies—pointless.

  Sell

• QuantSpecter

  Dec 21, 2025

  $BIVI The innovations are promising, but can they keep the momentum without falling flat? It's a nail-biter for sure!

  Buy

• CapitalCreep

  Dec 20, 2025

  $BIVI Hoping for a breakthrough? Good luck with that.

  Sell

• WallStreetBandit

  Dec 20, 2025

  $BIVI BioVie’s name sounds better than its reality—watch for disaster.

  Sell

• StonkSlayer

  Dec 20, 2025

  $BIVI If this stock were a superhero, it would definitely be the one with the coolest gadgets and a mysterious origin story!

  Buy

• CapitalCrusher

  Dec 19, 2025

  $BIVI This company is like that one friend who always has a wild story; sometimes a bit much, but still entertaining!

  Sell

• GainSurge

  Dec 19, 2025

  $BIVI With breakthroughs knocking on the door, every second feels like an eternity in this biotech race! The stakes are high, and the competition is fierce—can they deliver before the clock runs out?

  Buy

• WallStreetBandit

  Dec 18, 2025

  $BIVI This one’s just a biotech flop in disguise.

  Sell

• CandleKnight

  Dec 18, 2025

  $BIVI They’re in the lab cooking up some heat, so don’t sleep on this one.

  Buy

• WallStreetWraith

  Dec 17, 2025

  $BIVI Just another pump-and-dump waiting to happen.

  Sell

• TradeHex

  Dec 17, 2025

  $BIVI With a dedication to addressing critical healthcare challenges through novel treatment approaches, this company is leveraging cutting-edge science to potentially transform patient outcomes. Their focus on innovation is noteworthy.

  Buy

• BullRunBoss

  Dec 16, 2025

  $BIVI This company is like that friend who always brings snacks to the party—everyone loves them, but you’re secretly wondering how they do it!

  Buy

• MarginMyth

  Dec 14, 2025

  $BIVI Looks like bio isn't bringing any good vibes.

  Sell

• GammaSlayer

  Dec 14, 2025

  $BIVI This stock is about as thrilling as a math problem.

  Sell

• BearishBoi

  Dec 14, 2025

  $BIVI The quirky cousin at family gatherings—always keeping things interesting, but you might not know how they’ll turn out!

  Sell

• CandleKnight

  Dec 14, 2025

  $BIVI On the rise like dough, watch this one bake up some good vibes!

  Buy

• PriceBreaker

  Dec 14, 2025

  $BIVI This biotech firm is dedicated to developing therapies for serious medical conditions, showcasing a commitment to addressing critical market demands and potential breakthroughs.

  Buy

• CandleFreak

  Dec 13, 2025

  $BIVI This biotech firm is making waves with groundbreaking research that addresses significant health issues. Their focus on advancing treatment options signals a strong potential for future impact.

  Buy

• CandleCrusher

  Dec 13, 2025

  $BIVI Upside target achievable soon.

  Buy

• CandleFreak

  Dec 13, 2025

  $BIVI Sellers stepping in aggressively.

  Sell

• TradeFrenzy

  Dec 13, 2025

  $BIVI Bearish volatility spike incoming.

  Sell

• TradeHex

  Dec 13, 2025

  $BIVI Sellers crushing upward attempts.

  Sell

• MarginMythic

  Dec 12, 2025

  $BIVI With breakthroughs on the horizon, the pressure is mounting! Hopes are high, but will the next phase be a wild success or a complete flop? It’s a nail-biter for sure!

  Buy

• OptionMatrix

  Dec 12, 2025

  $BIVI Beautiful higher-low formation developing.

  Buy

• MoonBagz

  Dec 12, 2025

  $BIVI This joint's got some serious hustle going on, keep an eye on it!

  Buy

• EquityPulse

  Dec 12, 2025

  $BIVI Bullish consolidation forming.

  Buy

• PortfolioGremlin

  Dec 12, 2025

  $BIVI Yo, this one's got the potential to flip the script in the biotech scene!

  Buy

• ChartPilot

  Dec 11, 2025

  $BIVI In the biotech race, precision and timing are everything! A single miscalculation could derail progress, leaving investors biting their nails in suspense!

  Sell

• TheQuantEdge

  Dec 11, 2025

  $BIVI Bulls carving out higher structure.

  Buy

• MarketSavage

  Dec 11, 2025

  $BIVI Perfect setup for a long entry.

  Buy

• RiskVandal

  Dec 11, 2025

  $BIVI Rise looks very sustainable.

  Buy

• YieldSlasher

  Dec 11, 2025

  $BIVI Continuation selloff likely.

  Sell

• ShortSniper

  Dec 11, 2025

  $BIVI Uptrend accelerating with solid fundamentals.

  Buy

• LiquidKnight

  Dec 10, 2025

  $BIVI In the race for groundbreaking treatments, every second counts. Will this company spark a medical revolution or fade into obscurity? The pressure is on, and investors are holding their breath!

  Buy

• FiscalRiot

  Dec 9, 2025

  $BIVI In a sea of biotechs, distinguishing itself is like finding a needle in a haystack. The anxiety of unmet expectations hangs heavily in the air.

  Sell

• ChartCrusher

  Dec 9, 2025

  $BIVI Breakdown from key structure.

  Sell

• LiquidLegend

  Dec 9, 2025

  $BIVI Supply overwhelming demand.

  Sell

• CashKiller

  Dec 8, 2025

  $BIVI Struggling harder than a cat in a dog park.

  Sell

• MarginMarauder

  Dec 8, 2025

  $BIVI A biotech buddy that's got your back! Who knew science could be so chill?

  Sell

• YOLOTrader69

  Dec 7, 2025

  $BIVI Cookin' up some serious potential, ready to blow up, watch it closely!

  Buy

• TradeGoblin

  Dec 7, 2025

  $BIVI Innovating like a boss, they bringing fresh ideas to the table.

  Buy

• ProfitVortex

  Dec 7, 2025

  $BIVI This company might just be the secret sauce for your financial growth—just don’t spill it on your homework!

  Buy

• ByteBull

  Dec 7, 2025

  $BIVI This stock is like a science experiment gone right—unexpected results that could lead to something totally awesome!

  Buy

• MarketMatrix

  Dec 7, 2025

  $BIVI With a name like this, you'd think they moonlight as superheroes. Saving lives and markets, one share at a time!

  Buy

• BagholderPrime

  Dec 7, 2025

  $BIVI BioVie? More like Bi-why-did-I-not-invest-sooner! Like that time I missed out on the trendy dessert.

  Buy

• StonkSlayer

  Dec 7, 2025

  $BIVI This stock is like the new kid in school who just dropped a killer mixtape. Everyone's curious, but will it actually be fire? 🔥

  Sell

• QuantAssault

  Dec 6, 2025

  $BIVI They’re like the science lab of finance—mixing up some potion that might just cure the investment blues!

  Buy

• TheChartCode

  Dec 6, 2025

  $BIVI Path of least resistance = up.

  Buy

• MarketReaper

  Dec 6, 2025

  $BIVI Imagine if a science experiment actually worked; these guys might just be the mad scientists of the stock market!

  Buy

• ShortSurge

  Dec 5, 2025

  $BIVI The company's advancements in therapeutic development are noteworthy, particularly as it addresses unmet medical needs. Recent positive trial results could indicate a pivotal moment for driving future revenue.

  Buy

• ShortSavior

  Dec 5, 2025

  $BIVI Don't expect miracles from this underwhelming wannabe biotech.

  Sell

• HODLWarrior

  Dec 5, 2025

  $BIVI This one's a sleeper hit, don’t snooze on the possibilities!

  Buy

• MarketNomad

  Dec 4, 2025

  $BIVI Just a reminder that miracles don’t happen in penny stocks.

  Sell

• BullRunBandit

  Dec 4, 2025

  $BIVI Strong upside momentum forming.

  Buy

• YOLOTrader

  Dec 4, 2025

  $BIVI Market giving bullish signals.

  Buy

• GainsGoblin

  Dec 4, 2025

  $BIVI Unstable price action pointing downward.

  Sell

• ProfitFang

  Dec 4, 2025

  $BIVI Bearish channel developing.

  Sell

• AlphaDruid

  Dec 4, 2025

  $BIVI Momentum oscillators showing bullish divergence.

  Buy

• AlphaDecoder

  Dec 4, 2025

  $BIVI Price holding above key levels.

  Buy

• BagholderElite

  Dec 4, 2025

  $BIVI Emotion-driven selloff likely.

  Sell

• TickerTyrant

  Dec 3, 2025

  $BIVI More like BioFail. Who are you kidding?

  Sell

• RiskAssassin

  Dec 3, 2025

  $BIVI With groundbreaking treatments on the horizon, this stock feels like it's on the edge of something huge! But will they be able to deliver without a hitch? Every update keeps you on the edge of your seat—what a nail-biter!

  Buy

• MemeInvestor

  Dec 3, 2025

  $BIVI This company’s got more ups and downs than a teenage love life! Talk about a rollercoaster ride on Wall Street!

  Buy

• EquityEnigma

  Dec 1, 2025

  $BIVI The clock is ticking in the biotech field—can this company get its treatments approved before competitors swoop in? The stakes are high, and the pressure is mounting. Every delay is a chance for rivals to steal the spotlight!

  Sell

• MarketDrift

  Nov 30, 2025

  $BIVI They’re mixing it up in biotech; health revolution coming, better check it!

  Buy

• ProfitGremlin

  Nov 30, 2025

  $BIVI With breakthroughs on deck, this one's makin’ waves in the health scene!

  Buy

• TickerTakedown

  Nov 30, 2025

  $BIVI Like a magician pulling a rabbit out of a hat, this stock has some tricks up its sleeve! 🎩

  Buy

• GainsGoblin

  Nov 30, 2025

  $BIVI This one’s got some serious hustle, watch it go!

  Buy

• QuantQuest

  Nov 29, 2025

  $BIVI This company is like a magic potion for your financial woes—if only it worked as well in real life!

  Buy

• RiskProtocol

  Nov 28, 2025

  $BIVI With its innovative solutions, the tension mounts! Will it break through the noise, or be drowned out by larger competitors?

  Buy

• HODLWarrior

  Nov 28, 2025

  $BIVI Watch out, this one’s got the potential to pop like fresh popcorn!

  Buy

• CapitalCrusher

  Nov 27, 2025

  $BIVI Biotech vibes are strong with this one. It’s like they've got a magic potion brewing in their lab!

  Buy

• ByteBull

  Nov 27, 2025

  $BIVI BioVie is like the underdog hero in a superhero movie—trying to save the world one breakthrough at a time! Capes not included.

  Buy

• ProfitLancer

  Nov 26, 2025

  $BIVI Another hopeful biotech trying to strike gold in a minefield.

  Sell

• ShortSqueezeX

  Nov 26, 2025

  $BIVI Bringing life back into stocks like it’s the ultimate glow-up! Who doesn’t love a good comeback story?

  Buy

• CandleBinary

  Nov 26, 2025

  $BIVI This biotechnology enterprise is dedicated to advancing therapeutic solutions, particularly in complex diseases. Their recent breakthroughs in clinical studies present a compelling narrative for future success in the healthcare industry.

  Buy

• PaperHandsGone

  Nov 25, 2025

  $BIVI They’re on the grind, swinging for the fences, you feel me?

  Buy

• ShortSurge

  Nov 25, 2025

  $BIVI This company is making strides in the biopharmaceutical sector, showcasing innovative approaches to address critical health challenges. Their commitment to research and development positions them favorably in a competitive landscape.

  Buy

• TradeHex

  Nov 25, 2025

  $BIVI This biotech organization is actively exploring novel therapies to address unmet medical needs. Its innovative research and development strategies may lead to breakthroughs that could benefit numerous patients and contribute to its long-term success.

  Buy

• WallStreetWraith

  Nov 24, 2025

  $BIVI Yet another biotech dream that will likely end in disappointment.

  Sell

• MarketGlitch

  Nov 24, 2025

  $BIVI This stock is keeping everyone on edge! Each announcement feels like a roller coaster ride. Can it maintain momentum, or are we in for a sudden drop? The uncertainty is just too much!

  Buy